PHARMACYTE BIOTECH, INC. Debt Instrument, Interest Rate During Period
PHARMACYTE BIOTECH, INC. (PMCB) reported Debt Instrument, Interest Rate During Period of 1.00% for the 1-month period ending 2020-03-27, per its 10-K filed 2022-07-28.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateDuringPeriod · last filed 2022-07-28
- 2020-03-27: Debt Instrument, Interest Rate During Period 1 month 1.00%.
| Period end | Debt Instrument, Interest Rate During Period 1 month |
|---|---|
| 2020-03-27 | 1.00% 10-K · filed 2022-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |